V3 Group Limited, the Singapore-based holding company with a diversified portfolio spanning well-being, luxury gourmet, capital markets, real estate, and integrated healthcare services segments, announced today that its health and wellness supplements arm, LAC Global (LAC), has completed the acquisition of MASQUELIER'S French Pine Bark Extract (MASQUELIER'S). By acquiring MASQUELIER'S patented technology, LAC brings over 70 years of pioneering European nutritional science into its portfolio, combining proven scientific heritage with an Asian platform to build a mass-premium wellness proposition for global consumers.
Rooted in the work of renowned French scientist Professor Jack Masquelier, a pioneer in the research and development of oligomeric proanthocyanidins (OPCs), MASQUELIER'S is distinguished by its proprietary fingerprinted format's extraction expertise and decades of scientific research into the antioxidant properties of OPCs, supported by clinical studies.
Ron Sim, Founder and Executive Chairman, V3 Group, said, "Health is becoming one of the defining priorities for consumers globally. People are living longer, but the opportunity is to help them live better. The acquisition of MASQUELIER'S brings decades of European nutritional science into LAC, strengthening the scientific foundation of our portfolio. Singapore remains our home market, and we are grateful for the trust our customers have placed in us over the years. We remain committed to serving them through our extensive retail presence across Singapore's malls, even as we take LAC into new markets and pursue our ambition to build a health and wellness brand born in Asia for consumers globally."
MASQUELIER'S is also the originator and trademark holder of MASQUELIER'S Anthogenol, one of the most widely recognised OPC supplement brands across Asia Pacific. LAC's acquisition extends beyond a single product line to bring the foundational intellectual property and scientific heritage behind an established category into its portfolio. To date, MASQUELIER'S French Pine Bark Extract has sold over 250 million tablets, making it one of LAC's most significant and enduring product platforms across its Asian markets.
